Tanya Hayden

Chief Operating Officer at ACER THERAPEUTICS INC.

44 year

Health Technology

Consumer Services

Profile

Tanya Hayden is currently the Chief Operating Officer at Acer Therapeutics, Inc. She previously worked as the Director of Operational Excellence at Lonza Group AG from 2018 to 2021 and as the Vice President of Manufacturing at Bend Research, Inc. from 2014 to 2018.
Ms. Hayden completed her undergraduate degree at Gonzaga University.

Tanya Hayden active positions

Companies	Position	Start
ACER THERAPEUTICS INC.	Chief Operating Officer	2022-06-20

All active positions of Tanya Hayden

Former positions of Tanya Hayden

Companies	Position	End
LONZA GROUP AG	Corporate Officer/Principal	2021-05-31
Bend Research, Inc. Bend Research, Inc. Pharmaceuticals: MajorHealth Technology Bend Research, Inc. provides drug delivery and formulation development technologies. The company is headquartered in Bend, OR.	Corporate Officer/Principal	2018-03-31

See the detail of Tanya Hayden's experience

Training of Tanya Hayden

Gonzaga University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Tanya Hayden's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
LONZA GROUP AG	Health Technology

Private companies	2
Bend Research, Inc. Bend Research, Inc. Pharmaceuticals: MajorHealth Technology Bend Research, Inc. provides drug delivery and formulation development technologies. The company is headquartered in Bend, OR.	Health Technology
Acer Therapeutics, Inc. Acer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling on March 15, 1991 and is headquartered in Newton, MA.	Health Technology